Stimulation of excitatory synapses and neuronal density has been achieved with insulin-like growth factor 1 (IGF-1) administration and it has been positively tested in two single gene disorders associated with ASD, Rett syndrome, and Phelan-McDermid syndrome. This evidence concerns the gene IGF1 and Monosomy 22q13.